Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ag Novartis currently holds 5,908,089 shares of Aeglea BioTherapeutics, Inc. (AGLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ag Novartis has been a net buyer of AGLE stock. They have purchased $27.3M and sold $10.3M worth of shares.
Ag Novartis's most recent insider trade was on Jul 14, 2020, when they sold 5,908,089 shares at $0.00 per share.
Ag Novartis serves as Executive at Aeglea BioTherapeutics, Inc. (AGLE). They have executed 117 insider transactions totaling $37.6M over their tenure at the company.
Ag Novartis holds the position of Executive at Aeglea BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Ag Novartis has shown a buying trading pattern, with $27.3M in total purchases and $10.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ag Novartis was on Jul 5, 2017, when they purchased $4.0M worth of ALRN shares. This transaction involved 266,667 shares at $15.00 per share.
Ag Novartis currently owns 5,908,089 shares of Aeglea BioTherapeutics, Inc. (AGLE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ag Novartis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ag Novartis has 117 Form 4 filings on record as an insider at Aeglea BioTherapeutics, Inc..
Set alerts for Ag Novartis and 40,000+ other insiders.